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Successful differentiation of pluripotent stem cells into retinal cells and subsequent 
transplantation in animal models have made stem cell-based therapy a closer possibility for 
treating retinal degenerations. However, major limitations are low efficiency in deriving 
desired cell types and continued need for large animal studies to validate small animal 
studies. In this study, we modified a biopolymer scaffold with laminin-521 as a novel 
substrate to culture retinal progenitor cells (RPCs). We hypothesize that laminin-521 will 
increase cell retention and provide a developmental signal for RPCs to mature and self-
organize. The RPC scaffold culture was transplanted into a RD10 mice, a rodent model of 
retinal degeneration to evaluate the effects on disease pathology, and into pig eyes for a 
large animal pilot transplantation study. Differentiation of RPC was monitored by qRT-
PCR, immunofluorescence and immunoblotting. Graft survival, integration, and host 
immune reactivity was assessed via histology and immunofluorescence. The laminin-521 
coated scaffold (GCH-L521) increased cell attachment compared to non-coated scaffold. 
GCH-L521 was able to support growth and continued differentiation of RPC. When 
transplanted into animal models, the RPC scaffold graft survived in the host and did not 
cause significant host immune reaction. In RD10 mice, transplantation resulted in 
improved photoreceptor preservation. GCH-L521 can serve as a new substrate to culture 
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INTRODUCTION 
Pluripotent stem cells, such as embryonic stem cells (ESC) and induced pluripotent stem 
cells (iPSC), are promising tools for regenerative medicine and transplantation. There is 
growing research on stem cell therapy in neurodegenerative diseases, including 
Alzheimer’s, amyotrophic lateral sclerosis, and retinal degeneration [2-4]. Retinal tissue 
has been differentiated successfully from stem cells and demonstrated positive efficacy 
results when transplanted into rodent models. However, efficient cell cultures that produce 
transplantable tissue with long-term treatment efficacy remain a challenge.  
The Retina and Retinal Degeneration 
The retina is the neurosensory tissue that lines the inside of the eye; it processes and 
conveys light signals to the brain. An integral part of the retina is the retinal pigment 
epithelium (RPE), which forms the outer brain-retinal barrier and regulates ion and 
nutrition balance and waste removal from the retina [5]. The retina contains intricately 
connected layers of specialized neurons, all functioning to transduce electrical signal from 
the photoreceptors to the ganglion cells and to the CNS (Figure 1).  
Retinal degeneration describes the death of retinal cells from a variety of causes, 
leading to vision loss and reduced functionality for the patients. Two common forms of 
retinal degeneration are retinitis pigmentosa (RP) and age-related macular degeneration 
(AMD). RP is a heterogeneous disease caused by a number of genetic mutations affecting 
photoreceptor function, leading to degeneration [6]. The etiology of AMD is complex and 
likely a combination of genetic and environmental factors, and its pathology is thought to 
begin with degeneration of either the RPE or the photoreceptors [7]. Additionally, AMD is 
currently the leading cause of blindness in the elderly population of developed countries, 
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with 2 million people affected in the United States [8]. With the aging population, the 
prevalence in the US is projected to increase two-fold by 2020. From a public health 




Currently, treatments of AMD work to prevent progression of disease or to address 
the signs and complications of disease. In early stages of AMD, AREDS vitamins 
consisting of vitamin E, vitamin C, copper, zinc, lutein, and zeaxanthin, can be taken to 
retard progression to advanced disease characterized by abnormal neovascularization, but 
the efficacy is low [9]. The mainstay of treatment for advanced AMD involve laser 
procedures and intraocular anti-VEGF injections to prevent worsening pathology. For RP, 
there is currently no widespread, effective therapy. However, active research is looking 
into neuroprotective drugs, gene therapy and vision prosthesis for the disease [6]. Stem cell 
therapy is also under active investigation for AMD, RP and other retinal disease; this 
modality is aimed at replacing the deteriorating tissue of the retina to regain visual function.  
  
Figure 1. Eye anatomy and retinal layers. Histology of retina. Schematic diagram 
copied with permission from Kimbrel and Lanza, 2015 [1]. Histology photo 









Stem Cells Therapy for Retinal Diseases 
Stem cells have therapeutic potential due to their pluripotency state. Pluripotent cells can 
self-renew and differentiate into many different types of tissue; therefore, stem cells are a 
potential source of unlimited tissue for research and treatment. The embryonic stem cell 
(ESC) and induced pluripotent stem cell (iPSC) are pluripotent cells most commonly used 
to generate differentiated tissue. iPSCs are adult cells that have been reprogrammed back 
to a pluripotent state through the introduction of four transcription factors Oct3/4, Sox2, 
Klf4, and c-Myc, a method first described by Dr. Yamanaka in 2006 [10, 11]. Many types 
of specialized tissue cells are able to be differentiated from pluripotent stem cells, including 
retinal cells, pancreatic islet cells, hepatocytes, and neural progenitor cells, to name a few 
[12-14]. In order for stem cells to be therapeutic, the differentiated tissue must resemble 
native tissue in structure and function, and can survive and contribute to function within 
the host.  
 Retinal cells have been successfully differentiated from stem cells. RPE derived 
from ESC and iPSC exhibited similar pigmentation, morphology and gene expression as 
primary human fetal RPE [15-17]. With the appropriate culture conditions, stem cell-
derived RPE also developed the expected RPE functions, such as maintaining 
transepithelial resistance (TER) as an epithelium and phagocytosis of photoreceptor outer 
segments for waste removal [17-19]. Because RPE consists of one cell type, it is easier to 
differentiate to yield consistent, uniform cultures compared to differentiating the neural 
retina which contains many different types of retinal neurons. In part, due to this reason, 
stem-cell derived RPE has been more extensively studied than retinal progenitor cells 
(RPCs), with more data from both animal studies and patient clinical trials.  
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 However, in many retinal diseases including advanced AMD, the neural retina 
becomes damaged. Transplanting new RPE may better support the host retina but it 
ultimately does not replace the degenerating photoreceptors and other retinal neurons. To 
address this challenge, RPCs also have been differentiated from stem cells with the goal of 
recapitulating retinal development to produce the different neural retinal cells. Notably, 3D 
retinal organoids that resemble optic vesicles in early eye organogenesis have been cultured 
from stem cells using several approaches [20-24]. With time, these retinal organoids 
develop into retinal cups (RC) and acquired laminations containing cells that express 
markers for differentiating photoreceptor, amacrine, horizontal and ganglion cells. One 
group supported RC cultures for 27 weeks and demonstrated the formation of 
photoreceptor outer segment, a morphologic feature characteristic of photoreceptors and 
indicated maturation of these neurosensory cells [25]. A small number of these 
photoreceptors even exhibited electrical signal in response to a light stimulus measured via 
patch clamp; this encouraging result suggested some degree of functional maturation as 
well.  
 The long culture times and an ongoing need to generate mature functional retinal 
cells from RPCs remain major challenges to translating stem cell-derived retinal cups into 
treatments for patients. Many improvements have been made in the differentiation 
protocols for deriving RPE and RPC from stem cells. For example, RPE cultures can be 
enriched by supplementing ESCs with nicotinamide and activin A and Wnt and Nodal 
antagonists [19, 21, 26]. The substrates on which retinal cells attach and grow also play a 
critical role in the maturation process in culture. It has been shown that growing RPE cells 
on a porous mesh surface, such as poly(l-lactide-co-ε-caprolactone) and parylene-C coated 
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with extracellular matrix, resulted in more functionally and morphologically mature cells 
[27-29].  These studies demonstrated the importance of understanding the cellular niche 
conditions for growing and differentiating retinal cells. There is concurrent research in 
substrates and matrices that can facilitate maturation of RPC. 
Scaffolds and Laminin Proteins in Retinal Culture 
Early studies transplanting retinal cups containing RPCs or purified photoreceptor 
precursors in rodent models yielded promising results for cell engraftment with some 
functional improvement. However, the limitations were the low efficiency of cell survival 
and integration in the host retina [30, 31]. An additional limitation of using retinal cups for 
transplantation is the spherical shape of the organoids, which prevented the RPCs from 
laying as a flat sheet when implanted underneath the host retina. Investigators attempted to 
overcome this latter limitation by cutting retinal cups in half to decrease the degree of 
curvature [32]. However, control of retinal cup orientation was still challenging, as some 
cells reformed its more spherical shape.  
Three-dimensional scaffolds are being studied as a substrate for culturing RPC and 
as a vehicle for transplantation. Planar scaffolds can aid RPCs to grow in an organized flat 
conformation, which is easier to insert for subretinal transplantations. Additionally, 
scaffolds can support more RPC cells because they provide ample surface area for more 
cells to attach and proliferate [33, 34]. Some studies have shown that the mechanical 
properties of the scaffolds, such as stiffness and surface topography, can improve retinal 
differentiation. For example, polycaprolactone (PCL) scaffold etched with linear ridges 
and grooves promoted RPC proliferation and subsequent photoreceptor differentiation [35].  
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Previous work from Dr. Lawrence Rizzolo’s lab synthesized and characterized a 
novel 3-D scaffold for culturing RPC. The scaffold has a porous structure due to the 
lyophilization process and is composed of gelatin, chondroitin-sulfate, and hyaluronic acid, 
termed the GCH scaffold (Figure 2A). Larger scaffold blocks were sectioned into 60µm 
thick discs and RPCs were seeded onto the scaffold (Figure 2B). Previous results showed 
that GCH scaffold supported faster RPC differentiation from human ESC [36]. 
Additionally, RPC cultured on GCH had greater expression of markers for various 
differentiating neurons within the retina compared to RPC cultured on 2-D commercially 
available culture substrate. This project aimed to investigate a further modification of the 
GCH scaffold to improve the efficiency of RPC cultures. Laminin-521, an extracellular 
protein, was used to coat GCH scaffold before culturing RPCs.  
To promote cell attachment in cultures, scaffolds can be coated with extracellular 
matrix proteins such as collagen, fibronectin and laminin. Laminin proteins are found 
abundantly in the extracellular matrix of tissues. Laminins have a heterotrimeric structure 
comprised of an α chain, a β chain, and a γ chain, with each chain type having several 
isoforms. In addition to increasing cell attachment, laminins play important roles in 
directing polarized cell migration and retinal cellular function during the early development 
of the distinct retinal layers [37, 38]. Disruption of β2 chain, for example, can lead to 
abnormal photoreceptor morphology and loss synaptic formation [39].  
The laminin-521 used in this project is composed of α5, β2, and γ1 chains. We 
chose to coat the GCH scaffold with laminin-521 because and is the most abundant laminin 
in the internal limiting membrane (ILM) [40]. The ILM functions as a basement membrane 
separating the inner retina from the vitreous (Figure 1). As a basement membrane, it 
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provides a platform for cell attachment and cell compartmentalization. But the ILM also 
may function to maintain retinal polarity and ganglion cell organization. When the ILM is 
interrupted, there is significant loss of adjacent ganglion cells, disorganization of the 
ganglion cell layer, as well as retraction of neuron processes [41, 42]. These studies suggest 
that the ILM has a role in retinal cell differentiation and survival. Laminin-521 may be a 







Retinal Transplantation Studies 
A major goal of tissue engineering is to obtain a transplantable graft capable of replacing 
diseased tissue. Transplantation of stem cell-derived RPE and RPC have been studied in 
animal models, and clinical trials in humans are ongoing. Early transplantation studies were 
carried out in animal models of retinal degeneration such as the Royal College of Surgeon 
(RCS) rats, which has a mutation in MERTK and models retinitis pigmentosa [43]. ESC 
and iPSC-derived RPE transplanted in these rodent models resulted in less photoreceptor 
degeneration when compared to non-transplanted eyes [43-46]. Transplanted eyes also 
exhibited better visual function when measured with electroretinogram (ERG) or 
A B C Retinal Cups 
Scaffold in 
well 
Figure 2. GCH scaffold and culture model. A) scan electron microscopy of 
scaffold; image provided by Dr. Deepti Singh. B) thicker section of scaffold, to 
be sectioned into 60µm thickness C) RC containing RPC are seeded onto GCH 
scaffold in media. 
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optokinetic testing [45, 46]. These results highlighted the potential efficacy of RPE 
transplantation, but the challenges were how to maintain survival of transplanted cells and 
the functional improvement for the long-term.  
 In addition to RPE, transplantation of stem cell-derived RPC into animal models 
have also been investigated and demonstrated integration of RPCs with the host retina. 
RPCs migrated into the retinal layers and some cells formed synaptic connections with host 
retinal cells [31, 32, 47, 48]. On functional testing, transplanted eyes performed better than 
control eyes. As previously discussed, the culture conditions, such as substrates and trophic 
supplements, can affect the differentiation of RPC in significant ways. Qu et al. found that 
the length of time RPCs are cultured in suspension before being seeded onto a flat surface 
influenced whether the RPCs contained more retinal glial cells or neuronal cells [47]. When 
left in suspension culture longer, RPCs contained more neuronal cells and when 
transplanted in RCS rats resulted in better ERG signals than animals transplanted with 
RPCs that were differentiated for a shorter period of time in suspension. Ongoing research 
continues to investigate these nuances of the culture microenvironment in order to improve 
differentiation methods and achieve more mature and functional RPCs.  
 Despite the challenges of translating stem cell therapy to humans, RPE 
transplantation are being studied in patients. A phase I/II study transplanted human ESC-
derived RPE in patients with AMD and patients with Stargardt’s macular dystrophy. The 
results demonstrated safety and tolerability of the procedure as a primary endpoint [49, 50]. 
Visual acuity was measured as a secondary endpoint. After six months, four out of the nine 
AMD patients and three out of the eight Stargardt’s patient demonstrated improvement in 
 14 
visual acuity of 15 letters or more. Although patients on average scored higher on a 
subjective quality-of-life after their transplantation, the improvement in vision was modest.  
 Most recently, retinal transplantation using autologous iPSC-derived RPE was 
performed for the first time in a single patient. The patient’s skin fibroblasts were converted 
to iPSCs and then differentiated into RPE. Like the study mentioned above, the primary 
aim of the iPSC-RPE study was to demonstrate safety of the iPSC-derived cells [51]. The 
grafts were well-tolerated with no abnormal growth at the transplant site. Additionally, the 
patient’s vision neither improved nor decreased; however, without a comparison to the 
control eye, it is difficult to interpret this visual stability.   
 The next challenge in retinal transplantation clinical trials is to move beyond proof-
of-concept studies and demonstrate meaningful improvement in vision. To use research 
resources effectively, more preclinical work is still needed to explore ways of improving 
the efficacy of retinal transplantations. Large animal studies can play a role in filling this 
gap of knowledge. Pigs share many characteristics with the human eye; they have similar 
sizes and retinal vasculature. Physiologically, the electroretinogram signals are similar 
between pig and human eyes, and pig eyes contain a region (the visual streak) analogous 
to the human macula, where vision is the most acute [52-54]. Previous studies in the pig 
showed survival of transplanted RPC and RPE, with RPCs exhibiting some degree of 
integration with the host retina [55-58]. RPCs were able to mature further after 
transplantation in the pig retina [58, 59]. In addition, scaffolds were also tested as vehicles 
for transplantation in the pig [55, 59]. However, no large animal studies have studied stem-
cell derived RPCs in a 3-D scaffold model. This project also aimed to test the laminin-521 
coated GCH scaffolds in the pig. Further studies in large animals not only will allow 
 15 
refinement of transplantation techniques, they can also provide further insight into the 
physiology of the retina. 
Statement of Purpose 
Degenerative retinal disorders are debilitating diseases, for which there are no current 
effective treatments to reverse and restore vision. Stem cell based therapies are a possibility 
for restoring visual function, and both animal studies and clinical trial yielded promising 
results. However, the ongoing challenges are to improve the efficacy and consistency in 
differentiation methods and to derive tissue that can significantly restore function. The 
purpose of this work is to evaluate the modification of the GCH scaffold with laminin-521 
by assessing its ability to support RPC proliferation and differentiation. This project also 
transplanted the RPC scaffold model in two animal models, mice and pigs, to assess the 
biocompatibility of the scaffold and to evaluate for any therapeutic effects. 
Aims 
1.   To increase cell attachment and improve RPC differentiation by culturing on 
laminin-521 coated GCH (GCH-L521) scaffolds 
We hypothesized that laminin-521 coating will results in great numbers of RPC cell 
attachment and retention on the scaffold compared to non-coated scaffolds. 
Additionally, because laminin-521 is a prominent component of the ILM, the laminin 
coated scaffold may provide a differentiation signal and promote further maturation 
and polarization of neural retinal cells.  
2.   To ameliorate retinal degeneration in RD10 mice, a model of RP, by transplanting 
RPC GCH-L521 scaffold grafts 
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We hypothesize that the transplanted RPC scaffold graft will slow the degeneration of 
photoreceptors in the transplanted eye. Disease pathology will be assessed on histology 
and immunofluorescence. Functional recovery will be assessed with multifocal ERG.  
3.   To assess tolerability of scaffold culture graft in pig eyes and optimize post-
surgical immunosuppression protocol. 
We hypothesize that the approved surgical procedure and post-operative 
immunosuppression protocol will be sufficient to control post-operative inflammation 
and any immune reaction to the scaffold xenograft. Adverse effects of the procedure 
will be assessed with daily monitoring. Histology and immunofluorescence will be 
used to assess immune reaction at the tissue level. Dosage of prednisone steroids will 














GCH scaffold synthesis and laminin coating 
The planar scaffold was fabricated via a freeze dry process from gelatin (500mg), 
chondroitin sulfate (250mg), and hyaluronic acid (500mg) (GCH) dissolved in 10mL of 
distilled water [36]. Briefly, gelatin, chondroitin sulfate, and hyaluronic acid were 
dissolved in distilled water. The polymers were then crosslinked by adding reagents 
glutaraldehyde. The crosslinked solution was transferred into 3cc syringes to yield a 
cylindrical shape, frozen for 18hrs at -20°C, and then vacuum dried with a lyophilizer. To 
obtain thin circular scaffold disks, the cylindrical GCH monolith was frozen in OCT, and 
sectioned with cryotome with 60µm thickness.  
I sterilize scaffolds for cell culture by incubating scaffolds in 70% ethanol overnight. 
Then scaffolds were washed with PBS three times, then incubated in PBS with 10% 
penicillin-streptomycin for 30 min before incubating overnight in NIM. For laminin 
coating, GCH scaffolds were placed into individual wells in a 12-well pate without media.  
Laminin-521 is gently pipetted onto the scaffold for even coating, and then incubated at 
37°C for 30 min.  
 
Differentiation of retinal progenitor cells(RPC)- done by Tina Xia 
WA09 human embryonic stem cells were obtained from the Yale Stem Cell Center. WA09 
cells were cultured on plates coated with 1% Matrigel and in mTeSR-1 media. Media was 
changed every 1-2 days and spontaneously differentiating cells were removed under a 
sterile microscope.  
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 For RPC differentiation, a previously established protocol was used [20]. WA09 
cells are incubated with 1U/mL dispase for 30min at 37°C, then blebbstatin is added to the 
culture. The cells are then cultured in low-attachment, Lipidure-COAT Plates (Amsbio, 
Abingdon, UK) to induce embryoid body (EB) formation. On initial day of differentiation 
(D0), EBs were incubated in mTeSR-1. On D1, the EBs were switched to neural induction 
media (NIM) in 1:3 dilution with mTeSR-1. The NIM contained Dulbecco’s modified 
Eagle’s medium (DMEM) with high glucose, F-12 nutrient medium, 15% knockout serum, 
1% N2 supplement, 0.1mM 2-mercaptoethanol, 0.1M nonessential amino acids, 1mM 
glutamax, 50U/mL penicillin, and 50µg/mL streptomycin. On D2, EBs were incubated in 
NIM was mixed with mTeSR-1 in 1:1 dilution. From days 3 onward, EBs were incubated 
with only NIM. At D21, spherical retinal cups containing retinal progenitor cells were 
dissected away from the rest of the EB and seeded on GCH scaffolds. NIM was changed 3 
times per week. 
To assess cell attachment efficiency, ten EBs were seeded onto each sterilized 
scaffold, with or without laminin-521 coating. The number of EBs still attached to laminin-
521 coated or non-coated scaffolds was counted at 48hrs after seeding.  
 
Scaffold degradation assay  
Laminin-521 coated and non-coated scaffolds were incubated in PBS at 37°C with solution 
change every 3 days. Each week, the scaffold was removed from solution, dried on 
absorbent paper and weighed. Scaffolds were tested in triplicates. The data is presented as 




x -weight at certain week 
i -initial weight 
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Quantitative real-time RT-PCR  
Cellular RNA was extracted using the TRIzol reagent (Qiagen). RPC on GCH scaffold 
were sonicated in TRIzol briefly to dissociate the cells and the scaffold before extraction. 
1µg of total RNA was used for cDNA synthesis, using iScript Advanced cDNA synthesis 
kit (Bio-Rad). iTaqSYBR Green (Bio-Rad) was used for the real-time PCR reaction. 
Primer oligos were synthesized at the Keck Biotechnology Resource Laboratory. All 
samples were done in triplicates. Relative gene expression was normalized to GAPDH, and 
calculated using 2-∆∆Ct.  
 
Immunoblot 
Protein was extracted from WA09 cells or RPCs on scaffold by incubating in lysis buffer 
with protease inhibitor, 25mM Tris-HCl and 2% SDS. Samples were vortexed and 
sonicated to ensure adequate extraction from RPC in the scaffolds, then incubated at room 
temperature for 10 min. Samples were then centrifuged for 10 min at 4°C. Equal amount 
of protein were loaded into and ran in a 4-20% gradient PAGE gel according to 
manufacturer protocol. After transfer on to nitrocellulose paper, the blot was washed with 
TBST, blocked with 5% milk, and incubated with primary antibody overnight in 4°C. Then, 
the blot was washed again with TBST and incubated with secondary antibody according to 
manufacturer protocol. Chemiluminescent reagents were added to the bot and imaged with 





Immunofluorescence and confocal microscopy 
RPC cultures on scaffold were fixed with 4% paraformaldehyde (PFA) for 5min, washed 
with PBS, and incubated sequentially in 10% and 30% sucrose for 1 hour each. Then 
RPC scaffolds were incubated overnight in 1:1 solution of OCT and 30% sucrose at 4°C. 
Then RPC scaffolds were embedded in OCT and cross sectioned with cryotome to 12µm 
sections mounted on poly-lysine coated slides. Slides were allowed to dry for 48hrs 
before storing in -20°C. For staining, slides were washed 3 times with PBS and 
permeabilized for 1hr at room temperature with 0.30% Triton-X100 in PBS. After 
washing with PBS, slides were blocked with 10% donkey serum and 0.10% Triton-X100 
in PBS for 1hr. Samples were then incubated overnight at 4°C with primary antibodies in 
blocking solution, according to manufacturer recommendations on concentration. After 
washing with PBS, samples were incubated with secondary chromophore antibodies plus 
DAPI for 1 hr. After final PBS wash, slides were mounted for imaging.  
For preparing pig tissue slides, fresh harvested eyes were incubated in 4% PFA for 
1hr, then the cornea and iris is removed circumferentially and vitreous is carefully removed 
with gentle pipetting. The dissected eye is put back in 4% PFA for an additional 1-2 hrs at 
4°C. Then eyes are transferred to 10% sucrose for 6hrs, and then to 30% sucrose overnight 
in 4°C. Before sectioning, eyes are incubated in a 1:1 mixture of OCT and 30% sucrose for 
1 hr. Then, tissue is mounted in OCT, sectioned at 12µm thickness, and mounted on poly-
lysine coated slides.  
The migration of RPC on scaffold, with or without laminin-521, was assessed by 
DAPI staining to visualize the migration of cell nuclei. RPC differentiation was monitored 
by staining for retinal development markers PAX6, RAX, LHX2, CHX10, OTX2, CRX, 
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recoverin, BRN3, NEUROD1. For pig samples, TRA-1-85 stain was used to identify 
transplanted cells; IL-6 and IBA-1 were used to assess for inflammation and microglia 
activation, respectively, from transplantation. An LSM 410 spinning-disc confocal 
microscope was used to image the samples.  
 
Histology and hematoxylin and eosin staining 
Mice and pig eye tissue was collected, cryopreserved and sectioned onto poly-lysine coated 
slides as described above. Slides were stained with hematoxylin and eosin for tissue 
structure analysis. Images were captured using the OptraSCAN digital pathology scanner.  
 
RD10 mouse transplantation  
Mice experiments were in compliance with and approved by the Yale University 
Institutional Animal Care and Use Committee (IACUC). For scaffold transplantation, D21 
RPC on GCH scaffold were transplanted subretinally in RD10 mice. On postnatal day 30 
(P30), RD10 mice were adequately anesthetized by intraperitoneal injection of ketamine at 
100mg/kg. Using small surgical scissors, a small incision is made in the lateral conjunctiva 
and sclera of one eye and 1µL of PBS was injected between the choroid and retina to create 
a small retinal detachment. A 0.5cm x 0.5cm piece of scaffold with RPC was inserted in 
the potential space using forceps. RD10 mice were kept in a dark environment for 1-2 days 
after transplantation, then returned to routine animal facility maintenance. Eyes were 




Pig optical coherence tomography (OCT) and multi-focal electroretinogram (mfERG)-  
OCT was acquired while animals were under anesthesia either before surgical procedure 
or before euthanasia. Two drops of phenylephrine 2.5% and tropicamide 1% each were 
applied to the test eye for dilation. A Cirrus HD-OCT 4000 (Zeiss) was used to capture the 
OCT, using the Macula Cube 512x128 scan pattern. Animals were positioned up to the 
lens, and OCT was scanned when images of good signal can be detected.  
 For the mfERG, measurements were taken before surgery procedures or before 
euthanasia. The surgery or control eye of sedated animals were dilated as described above. 
A RETImap machine (Roland Consult, Germany) was used to capture the mfERG. The test 
animal was covered with a field shielding blanket to reduce electrical noise artifacts during 
measurement. In addition, all unnecessary electronics were shut down during mfERG 
recordings. 2.5% hypromellose eye lubricant was applied on a contact lens ERG electrode 
and placed on the cornea. Two reference electrodes were placed in the skin of the animal’s 
scalp and front leg. The animal, machine, and shielding blanket were grounded. mfERG 
measurements were captured according to manufacturer’s protocols. A minimum of 10 
cycles were ran per recording to obtain reliable mfERG waveforms.  
 
Pig retinal transplantation 
Pig experiments were carried out in compliance with Yale University IACUC regulations 
and with approved protocols. Yorkshire breed pigs were used for all transplantation 
experiments. Animals were sedated by Yale veterinarian services. 0.2mg/kg of atropine 
was given intramuscularly at the time of sedation by veterinarians. Additional drops of 
phenylephrine 2.5% and tropicamide 1% were applied to surgical eye. The eye and 
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surrounding skin was cleaned with 10% providone-iodine solution and then surgically 
draped. A 23G pars plana vitrectomy was done to remove the vitreous. Sterile saline 
solution was injected subretinally using a 38G cannula to create a bleb. The retinal incision 
site on the bleb was cauterized with diathermy to prevent bleeding. A retinotomy was made 
using microscissors along the cauterized retina. The scaffold was placed flatly in the 
subretinal space using a specialized inserter device. Fluid-air exchange (FAX) was done to 
flatten the transplant site, and air was left in the globe to tamponade the retina. Scleral 
incision sites were sutured if needed to prevent gas leakage from the eye. At the completion 
of surgery, 1mg of triamcinolone was injected intravitreally and 50mg of cefazolin was 
injected under the conjunctiva. (Surgery done by Dr. Ron Adelman and Dr. Scott Ketner, 
assisted by Tina Xia) 
 Animals given a buprenorphine patch for the three days post-operatively and 
systemic steroids (prednisone 2mg/kg) every day until end of experiment. Animals were 
monitored daily for ocular and systemic symptoms.  
 
Statistical Analysis 
Statistical analysis was done using unpaired t-test and one-way ANOVA. Standard error 





Laminin-521 was coated onto pre-fabricated gelatin-chondroitin sulfate-hyaluronic acid 
(GCH) scaffolds via electrostatic bonding. Therefore, GCH-L521 scaffolds retained the 
same porous structure as non-coated GCH scaffolds. To assess whether laminin-521 
affected the structural integrity of the polymer scaffold, a simple degradation assay was 
done which showed less degradation of the laminin-521 coated scaffold by week 1 and 
week 2 compared to non-coated scaffolds. By week 3, there was no significant difference 
between the two types of scaffolds (Fig 3). It is noted that there was greater variability in 
the weight measurements at three weeks, which may explain the non-significance observed 





Laminin-521 coated GCH scaffold promoted higher cell attachment and migration 
on scaffold.  
Laminin-521 is the predominant laminin protein found in the ILM, and is thought to play 
a role in embryonic retinal development [40, 60]. Therefore, we hypothesize that laminin-
521 modification of the GCH scaffold may facilitate cell migration into the scaffold matrix. 
Figure 3. GCH scaffold 
degradation assay. Wet weight was 
measured and normalized to initial 
scaffold weight. Experiments done 

























As an initial experiment, embryoid bodies (EBs) were seeded onto laminin-521 coated 
(GCH-L521) and non-coated scaffolds (GCH) and the percentage of EB attachment after 
48 hours was calculated. About 25% more EB cell clusters were attached to laminin-coated 
scaffolds compared to non-coated ones (Fig 4A). Cell migration was assessed by imaging 
cell nuclei within the scaffold thickness. When retinal cups containing RPCs were seeded 
onto GCH-L521, the RPCs populated the pores of the scaffold and migrated through its 
entire thickness (Fig 4B, C).  













Laminin-521 GCH scaffold supported the differentiation of RPC 
Although cells were able to attach and migrate on the GCH-L521 scaffold, it is essential 
that the scaffold also supports continued differentiation of RPC into the different types of 
retinal cells. Nine days after seeding on scaffold (total day 30 of differentiation), RPC 
























Figure 4. A) Cell attachment on GCH-L521 scaffold 48 hours after 
seeding. ± SEM. B) En face view of RPCs in scaffold. DAPI stains cell 
nuclei. C) Cross sectional image of RPC nuclei in GCH-L521. Scaffold 
thickness is 60µm.  
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transcription factor that helps to initiate retinal development from the anterior neural plate 
and later mediates Müller cell gliogenesis [61, 62]. RAX is a homeobox gene also involved 
in directing early retinal differentiation and retinal stem cell proliferation [63]. PAX6 is an 
important master regulator that is actively expressed in RPCs during differentiation [64]. 
In the D30 cultures, RPC on laminin-521 coated scaffolds expressed LHX2 and PAX6 at 
significantly higher levels than RPC on non-coated scaffolds (Figure 5A). Ki67 is a marker 
for actively proliferating cells. Although Ki67 expression in both laminin-coated and non-
coated cultures decreased compared to early D3 cells, RPC on GCH-L521 had higher Ki67 
expression than on non-coated scaffolds, indicating possibly higher cell proliferation on 
laminin-coated scaffolds (Figure 5A).  By D42 (three weeks after seeding onto scaffold), 
retinal differentiation between laminin-coated and non-coated cultures are comparable, 
with similar expression of RAX, BRN3 and SIX6. RPC on non-coated GCH scaffolds 
expressed higher levels of PAX6, LHX2 and NEUROD1 by D42 (Figure 5B). At this later 
time in differentiation, markers of retinal cell specification began to be expressed. 
NEUROD1, for example, is a transcription activator that mediates retinal ganglion cell and 
amacrine cell differentiation[65], and BRN3 is active in ganglion cell differentiation[66].   
Expression of NANOG and OCT4 were monitored to ensure differentiation away 
from the pluripotency state. Interestingly, by D30, the expression of NANOG and OCT4 
were increased compared to early baseline expression (D3) in both scaffold cultures, most 
notably being OCT4 levels. However, by D42 the pluripotency genes decreased in both 
cultures, but to a greater degree in the laminin-coated scaffold cultures compared to non-
coated scaffold cultures (Figure 5A, B). The unexpected continued expression of NANOG 
and OCT4 prompted closer examination of the expression of these genes in the early weeks 
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of culture. NANOG expression in both coated and non-coated scaffold cultures increased 
above baseline and peaked at D21 and then downregulated, with significantly decreased 
expression at D42 (Figure 5C). OCT4 exhibited a similar expression pattern, with initial 
upregulation which peaked at D30 and then decreasing expression (Figure 5D). Persistence 
of pluripotency genes would be a concern for uncontrolled growth or differentiation. 
However, our laminin-coated scaffold cultures demonstrated downregulation of NANOG 









































































































Figure 5. qRT-PCR assay of genes. A) Gene expression at D30 of culture, in L-
521 coated and non-coated RPC cultures. B) mRNA levels in D42 cultures. C) 
Expression of NANOG through 42 days of differentiation. D) Expression of OCT4 
with time in differentiation. ± SEM, ****p< 0.0001, **p< 0.01, *p< 0.05 
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Assessing gene expression of GCH-L521 RPCs at D61, NANOG and OCT4 were 
significantly downregulated at that time, and retinal specifying genes were upregulated to 




RPC protein expression of retinal differentiation markers 
Immunofluorescence assays were carried out to monitor expression of appropriate retinal 
differentiation proteins in RPCs cultured on GCH-L521 scaffold. Figure 7 shows an 
example cross-sectional stain of RPCs on the planar scaffold. The scaffold autofluoresces 
in each color channel. At D42, RPCs on GCH-L521 expressed the early eye field markers 
PAX6 and LHX2, consistent with qRT-PCR data. At lower magnification, one can discern 
pockets of RPCs where one gene is expressed greater than the other, i.e. brighter 
fluorescence of one marker (Figure 7A). This patterning may indicate active differentiation 
of RPCs into the varying types of retinal cells. Further along in culture, RPCs expressed 
markers indicative of continued specification of RPCs. CRX and OTX2 are both homeobox 
proteins that contribute to photoreceptor differentiation from progenitor cells during 



































Figure 6. RPC 
differentiation at D61 on 
GCH-L521. NANOG and 
OCT4 were significantly 









Figure 7. D42 RPC on 
GCH-L521 scaffolds. A) 10x 
images; scale bar 50µm. 
Homogenous fluorescence is 
the autofluorescent scaffold. 
B) 40x images; scale bar 
20µm. Dotted line 
demarcates the bottom edge 
of scaffold.  
Figure 8. D51 RPC on GCH-L521 scaffold. A) photoreceptor differentiation 
with CRX, OTX2 and recoverin expression; co-localization of OTX2 and 
recoverin. Scale bar, 20µm. B) CHX10 expression, suggesting bipolar cell 
specification. Scale bar, 20µm. 
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Recoverin, a photoreceptor protein, was also expressed by RPCs and co-localizes with 
OTX2 (Figure 7A). 
CHX10 is a factor expressed early in retinal development to maintain RPC 
proliferation and subsequently mediates bipolar cell differentiation [70, 71]. RPCs on 
GCH-L521 expressed CHX10 at D51, suggesting differentiation into retinal interneurons 
(Figure 8B). By D77 in culture, additional markers of inner retinal layers were expressed 
(Figure 9). HuC/D is a protein expressed in developing ganglions, horizontal and amacrine 
cells [72, 73], and BRN3 is a ganglion cell marker [72]. Photoreceptor remain 






Immunoblot assays confirmed the immunofluorescence data of early cell cultures. 
In very early D3 cultures, LHX2, PAX6, recoverin and BRN3 were at undetectable levels. 
However, all four proteins were upregulated by D71 (Figure 10).  
D	  77 




BRN3 is a ganglion cell 
marker. Rhodopsin is a 




Segregation of RPC into retinal cell types 
Basement membranes are critical parts of tissue structure because they provide cell 
adhesion points and regulate cell organization. The ILM has been shown to mediate retinal 
lamination and Müller cell organization [37, 74, 75]. Our hypothesis is that the laminin-
521 coated scaffold, can act effectively as an ILM, and induce self-organization and 
lamination of the cultured RPC. In some RPC clusters cultured on GCH-L521, specific cell 
types began to segregate, forming gross laminations. Recoverin+ cells (photoreceptor-like 
RPCs) segregated from BRN3 (ganglion cell-like RPCs) (Figure 11A). In other clusters, 
recoverin+ cells formed distinct layer from LHX2+ cells (likely differentiating Müller cells) 
(Figure 11B). It is important to note that such gross lamination was not observed 






BRN3 Recoverin	   
Actin Actin 
Actin Actin 
Figure 10. Immunoblot 
of retinal differentiation 
proteins. Actin blotted 
as control.  
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RPC scaffold cultures preserved more nuclei in degenerating photoreceptors  
A transplantable tissue ideally will survive and integrate with the host retina to establish 
functional connections with host cells. RPCs cultured on laminin-521 coated GCH scaffold 
were transplanted into RD10 mice to assess the effect of the graft in a degenerating retina. 
The RD10 mouse model contains a mutation in a rod-phosodiesterase gene (PDE6B) that 
causes photoreceptor death and subsequent inner retinal degeneration [76, 77]. RD10 mice 
provides a model of autosomal recessive retinitis pigmentosa (RP) in humans. 
Degeneration begins around three to four weeks after birth with rapid loss of 
photoreceptors in the outer nuclear layer (ONL).  
After retinal cups containing RPC have differentiated on GCH-L521 scaffold for 
three weeks, scaffold cultures were transplanted subretinally in RD10 mice on postnatal 
day 30 (P30). Eye tissue was collected ten weeks after transplantation (P100). By that time, 
the scaffold appeared to have biodegraded, with no fluorescence evidence on microscopy. 
Transplanted RPC survived in the host retina and could be identified with TRA-1-85, a 
Figure 11. Gross RPC laminations observed in some cell clusters. A) BRN3+ 
cells segregating from recoverin+ cells. Scale bar, 20µm. B) Recoverin+ 
(green) cells layering next to LHX2+ (magenta) cells. Scale bar, 50µm.  
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marker for human-derived cells (Figure 12). The RPC also stained positive for recoverin 
indicating that the transplanted cells maintained their differentiation. As a control, no TRA-
1-85+ cells were found in the non-transplant eye as expected. By 14 weeks of age (time of 
tissue harvest), the ONL of RD10 mice has degenerated to a single layer of photoreceptors 
(Figure 12, control). In the transplant eye, more photoreceptor nuclei were present at the 
transplant site. The transplanted TRA-1-85+/recoverin+ cells contributed to the ONL 
(Figure12, transplant), indicating the ability for the scaffold graft to mitigate the cells loss 
in retinal degeneration.  
 
In some regions of the transplant area, transplanted RPCs were observed to have 
migrated deeper into the host retina. TRA-1-85+ cells moved into the inner nuclear layer 
(INL), where horizontal, amacrine, and bipolar cells are located, and into the inner 
plexiform layer (IPL), which is composed of dendrites of ganglion cells (Figure 13). The 
Figure 12. Transplanted RPCs in RD10 mouse retina, identified by TRA-1-85 
(human cell marker). Tissue analysis done at 10 weeks post-transplantation. 
Recoverin stains for photoreceptors, which compromises the outer nuclear layer 
(ONL) of the retina. Arrow heads point to the number cell nuclei in the ONL. 
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TRA-1-85+ cells that migrated into the inner retina were not recoverin positive, suggesting 
that these migrating RPC were likely of another retinal cell lineage than photoreceptors.  
  
To assess for changes in visual function, multifocal electroretinogram (mfERG) 
were measured on the transplanted RD10 mice. ERG measures the electrical signals from 
the retina in response to light stimulation. The ERG can be used to monitor retinal 
degeneration as signal transduction becomes slower and lower in amplitude [77]. mfERG 
is a variation of this testing where electrical activity can be correlated to specific areas of 
the retina. We measured the mfERG of RD10 mice before after transplantation to evaluate 
for any functional recovery (Figure 14). A characteristic mfERG waveform is shown in 
Figure 14B. The N1 peak correlates to photoreceptor activity after a light stimulation, and 
the P1 peak correlates to transmission of signal to the bipolar cells in the inner retina. 
Proper photoreceptor function is necessary for robust P1 waves. As expected, our data 
shows that at time of transplantation (post-natal day 30, P30), P1 amplitude is similar to 
wild-type (WT) because degeneration is in the early stages. Four weeks post-
transplantation, mfERG was measured again, showing significantly decreased amplitudes 





Figure 13. Transplanted RPCs migrating from graft site into the inner retina. 10 
weeks post-transplantation. ONL- outer nuclear layer; INL- inner nuclear layer; 











































































































Figure 14. mfERG of RD10 mice before and after transplantation. A) Idealized 
mfERG waveform. Adapted from Dutescu et al. (89) B) Representative fundus 
photograph of area of retina where measurements were taken. C) P1 wave amplitude, 
values of the measurement area were averaged D) Peak time of P1 wave; values of 
measurement area were averaged. Pre-transplant measurement taken at post-natal day 
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significant difference between the transplanted eye and the non-transplanted eye. Peak time 
is another informative parameter in ERG measurements. It is the time from the onset of 
light stimulus to the peak wave amplitude. This time measurement is an indication of the 
signal transduction within the retina and can become delayed in retinal disorders when 
neuronal connections are disrupted [77, 78]. In our experiment, the peak time was already 
delayed at the time of transplantation compared to WT. Repeat measurement four weeks 
later did not show significant changes in peak times, in either the transplant or non-
transplant eyes (Figure 14D).    
 
Preliminary data on good tolerability of GCH-L521 scaffold in pig eyes 
For a retinal graft to be ultimately used in human treatments, it is ideal to conduct 
transplantation studies in large animals, whose eyes are more anatomically and 
physiologically similar to human eyes. Results from large animal studies can allow further 
optimization of retinal grafts. We began a pilot study transplanting RPCs scaffold grafts 
into normal pig eyes. The initial aim of the pilot study was to evaluate whether our 
immunosuppression protocol was sufficient to control the pig immune reaction against the 
RPC xenograft. Data has been collected from eight transplantation procedures so far: four 
animals received RPC on GCH-L521 scaffold, one animal received only GCH-L521 
scaffold with no cells, another one received only polyester (PET) transwell filter, one 
animal received hESC-derived RPE on PET filter, and the last animal received a co-culture 
of RPC and RPE. Table 1 provides the details of each animal surgery.  
Mild redness and swelling of the conjunctiva was present immediately following 
surgical procedures, but typically resolved completely after two days. Subsequently on 
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daily monitoring, no animals showed gross signs of ocular inflammation, such as enlarged 
blood vessels on the conjunctiva or sclera, hazy cornea, or debris in the anterior chamber. 
On histology, mild folding of the retina was observed mainly around the transplantation 
region (Figure 15). Additionally, no infiltrating cells or granulomas were present; the 
architecture of retinal layers remained fairly intact. To assess immune reactivity at the 
tissue level, retina tissue sections were stained for IL-6 and IBA-1. IL-6 is a cytokine that 
is highly expressed in inflammation and during graft rejection, and IBA-1 is a marker for 
microglia, which can assess for increased immune reactivity [79, 80]. The scaffold was 
placed to lay flatly between the retina and the RPE/choroid. I examined the two sides of 
the graft on immunofluorescence, one side abutting the retinal ONL and the other abutting 
the choroid. There was no significant difference between IL-6 staining between the 
transplanted and the non-transplanted control eye, indicating no upregulation of the 
inflammatory marker (Figure 16). In the control eye sections, IBA-1 staining identified the  
resident microglia cells within the choroid and retina (Figure 16). In transplanted eyes, 
IBA-1 positive staining appears mildly increased on the choroid side but not significantly 
increased on the retina side compared to control eye. No adjustment of our 
immunosuppression protocol was made. In the animals that received RPC on GCH-L521 
scaffolds, few TRA-1-85+ cells were found at the transplant site (Figure 17). Compared to 
the quantity of RPCs transplanted initially, there was significant cell loss at 22 days after 
transplantation.   
 Complications were observed mainly at the tissue level on dissection (Table 1). As 
mentioned above, the most common complications are mild scarring and wrinkling of the 
retina around the transplantation site (Figure 15) and vitreous debris. Less common, but  
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more serious complications were retinal detachment and lens opacification; both were 
most likely caused by inadvertent trauma during the surgical procedure. The two latter 





Figure 15. H&E stain of pig retinal sections. Non-transplant section 
shows retinal architecture of the non-operated eye. Transplant site is 
where the scaffold was inserted. Transplant adjacent is the areas around 
the insertion site, where retinal architecture remained normal.    
Figure 16. Few transplanted RPCs (TRA-1-85+) found around the graft 
transplantation site. TRA-1-85+ cells were not positive for recoverin. Scale 











Figure 17. Immunoreactivity of scaffold in the host retina. Representative 
immunofluorescence sections. Scaffold was inserted flatly between the retina 
and choroid. IBA-1 and IL-6 positivity was assessed on both sides of the 
















344 -GCH   
-No cells 
12 days -Triamcinolone (intraocular) 
1mg/eye 
-Gross pathology:  
  Posterior lens opacification 
  Large retinal detachment 
  Vitreous scarring/traction 
358 -GCH-L521 
-D16 EBs 
8 days -methylprednisone 2mg/kg IM 
(pre-op, once) 
-Triamcinolone (intraocular) 
-Prednisone 2mg/kg PO daily 
- Gross pathology: 




15 days Same as above (#358) -Gross pathology: 
  Trace vitreous debris 




22 days Same as above -No major complications 
376 -GCH-L521 
-D23 RPCs 
22 days Same as above -Gross pathology: 
  Vitreous debris 
  Mild retinal scarring 
382 -hESC-RPE 
on PET filter 
20 days Same as above -Gross pathology: 
  Posterior lens opacification 
  Vitreous debris 
  Retinal scarring 
383 Co-culture: 
-D56 RPC on 
GCH-L521 
-hESC-RPE 
on PET filter 
29 days Same as above -Gross pathology: 
  Mild retinal scarring at 
transplant site 
 
Table 1. Summary of pig retinal transplantations. Grafted cells and scaffold, follow-
up length, immunosuppression regimen, and complications are listed. PET- polyester; 
IM- intramuscular; PO- per os (by mouth).  
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Challenges in pig retinal transplantation 
Our preliminary results suggested the immunosuppression was sufficient and the GCH-
L521 scaffold has good biocompatibility. A secondary goal of the pig project was to 
optimize mfERG measurements of pig eyes in order to monitor in visual function after the 
surgical procedure. Previous work in the Rizzolo lab conducted mfERG measurements of 
pig retina after laser injury and was able to distinguish the light sensitive visual streak from 
non-visual streak areas of the retina (YSM Thesis of Laurel Tainsh). We attempted to 
measure mfERG before and after intraocular transplantation procedures. The major 
challenge was reducing the environmental interference that contributed to the background 
artifact of the measurements. The best attempt was made to block interfering 
electromagnetic fields: animals were covered with a field shielding blanket, and all 
unnecessary electronics were turned off during measurements. However, because we could 
not shield the entire surgical room and the sedated animals must continue to be monitored 
on the ventilator, the existing artifacts contributed to inconsistent mfERG measurements. 
This inconsistency hindered comparison of measurement values from before to after the 
transplantation (see Figure 19A).  
 Another challenge to acquiring consistent and reliable mfERG was the difficulty in 
positioning the pig’s eye for imaging. Unlike human subjects who can be instructed to look 
in specific directions to image a particular area of the retina, this was not possible in sedated 
animals. Occasionally, superficial sutures were put through the sclera of the animal to pull 
the eye in desired directions; however, even with manipulation of the animal’s eye, there 
could be significant movement during the measurement period, contributing to 
unreliability of the recordings. Similarly, on follow-up after transplantation, it was 
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sometimes difficult to position the eye to access the same area of the retina measured on a 
previous test. Figure 19B shows an example of good mfERG measurements taken before 
and after transplantation in an animal, however, the region of the retina that was measured 
did not correspond closely, limiting subsequent comparison.   
 OCT is a non-invasive imaging modality that captures cross-sectional images 
through the retina and allows evaluations of retinal tissue architecture, similar to ultrasound 
images. OCT is potentially very useful in retinal transplantation studies because it is a quick 
study and can reveal signs of complications without having to collect tissue. Figure 18 
shows an example of mild retinal folding at the scaffold transplantation site, but no major 
retinal detachments. However, the difficulty with positioning was also a major challenge 
in using optical coherence tomography (OCT) to monitor transplanted graft in vivo. It was 
difficult to obtain consistent OCT images of the same area in the retina on subsequent 





thickening: scaffold? Figure 18. Example OCT 
images. Changes in retinal 
architecture can be imaged, 
including retinal folds, 
retinal or subretinal thinning 
or thickening. Images on 
right are the fundus 
photograph of the imaged 
area. Blue line- where cross-




















Besides overcoming the technical challenges of large animal studies, the surgical 
capacity of the animal facilities is also important in obtaining meaningful data in an 
efficient way. This pilot study was the first large animal retinal transplantation study 
carried out at Yale University. The Yale Animal Resources Center (YARC) provided the 
veterinarian and anesthesia support for the surgical procedures. Veterinarians were also 
















































































































































































Figure 19. Example mfERG recordings. A) Inconsistency in 
controlling background signal noise. Pre-transplant mfERG noisier and 
lower than post-transplant measurements. B) Challenge in consistent 
positioning. Good pre- and post- transplant measurements, but difficult 
to align to the same retinal location. 
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optimize mfERG recordings. One main limitation was the low operational capacity of the 
animal facility. Due to the time required for mfERG and OCT measurements, one survival 
animal procedure can realistically be done in a single day; and commonly one to two 
survival procedures can be done in a week, given personnel availability and facility 
regulations. The low capacity slowed the optimization process for the surgical procedure 
and data collection. Moving forward, increasing the number of procedures per week would 
allow experimenters to become even more facile with the transplantation procedure and to 















Retinal degeneration, such as retinitis pigmentosa and AMD, are debilitating disease 
causing visual impairment and blindness. Currently, there are no treatments that effectively 
reverse disease or can replace dying retinal tissue. The ability to differentiate stem cells 
into retinal cells holds promise for developing transplantable grafts that can lead to vision 
recovery.  More research is investigating the use of scaffolds to culture retinal progenitor 
cells (RPCs) for transplantation. The mechanical and physical properties of the scaffold, 
such as stiffness, elasticity, and having nanowires or grooves, can be modified to improve 
the efficiency of the differentiation process [34, 35]. Another advantage of using scaffolds 
is possible higher retention of cells during transplantation. Currently, many transplantation 
studies including human clinical trials implant cells by injecting a cell suspension [19, 50, 
81] . However, this method leads to significant cell loss, either from reflux of cells during 
injection or cell death due to lack of connection with other cells while in suspension. A 
scaffold model would not only allow cells to remain adherent but also support synaptic 
connections between developing neural retinal cells. Subsequently, the entire composite 
graft can be transplanted subretinally.  
 Previous studies of retinal cultures on scaffold mostly studied RPE cultures, and 
scaffolds attempted to mimic the RPE basement membrane composition. Our scaffold 
model is unique because it attempts to culture human ESC-derived RPC on a scaffold with 
3-dimensional depth. The novel scaffold is synthesized from gelatin, chondroitin sulfate 
and hyaluronic acid to closely mimic the compositional ratio of the natural extracellular 
matrix (EMC) of the retina [82]. The aim of the culture model was to coerce the RPCs to 
use the 3-D structure of the scaffold to self-organize into the natural layers of the retina. 
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However, initial results from our lab showed that RPCs did not readily migrate into the 
depth of the scaffold; most RPCs remained clustered on top of the scaffold [36]. My project 
sought to address this limitation by modifying the scaffold further by coating it with 
laminin-521. Existing studies on scaffold cultures coated them with ECM, including 
laminin and collagen, to mimic the natural retinal ECM and increase cell adherence [29, 
34]. Similarly, we hypothesized that laminin-521 would increase RPC attachment on the 
GCH scaffold. Additionally, because laminin-521 is the dominant laminin of the ILM, it 
may provide a basement membrane signal and direct tissue organization.  
  Our data demonstrated that the laminin-521 coated GCH scaffold improved cell 
attachment and migration within the scaffold. Higher cell retention in culture increases the 
yield of differentiating retinal cells, which enables more experimentations and data 
collection. The laminin-521 modification increased cell migration to populate the entire 
thickness of the scaffold and is an important first step toward achieving a 3-D self-
organizing retinal tissue culture.  
Importantly, the RPCs seeded onto GCH-L521 scaffold continued to differentiate 
and expressed developmental markers of different interneurons within the retina. 
Photoreceptors had begun developing by day 51 in culture, and there was also evidence of 
differentiating bipolar cells at that time. By day 77, differentiating ganglion cells began to 
appear within the scaffold culture. Interestingly, the pluripotency markers NANOG and 
OCT4 were expressed to significant levels into day 30. In other studies, expression of 
pluripotency gene decreased earlier in the retinal differentiation process [19, 22]; one study 
demonstrated that ESC differentiated into neural phenotype with significant 
downregulation of OCT4 by four weeks in culture [19]. The continued expression of 
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NANOG and OCT4 may be an effect of the laminin-521 modification. Laminin-521 is 
found in abundant levels in the stem cells niche of human ESCs as well [83, 84]. In culture, 
the laminin-521 substrate contributes to the maintenance and expansion of ESC, and it is 
now commercially available for growing ESC cultures [84]. Therefore, in the context of 
the blastocyst in embryonic development, laminin-521 may play a role in maintaining the 
pluripotency of ESCs. This property could explain the persistence of NANOG and OCT4 
in our cultures during RPC differentiation. Having undifferentiated cells can be a concern 
for possible uncontrolled cell growth, however, our results demonstrated that by day 42 in 
differentiation media, both pluripotency markers were significantly downregulated, with 
continued expression of appropriate retinal markers.  
We hypothesized that laminin-521, a component of the ILM, would provide a 
developmental signal to promote lamination of RPCs within the scaffold. Gross 
laminations were observed in some RPC clusters on the scaffold, where developing 
photoreceptors are segregating from the ganglion cell precursors. The RPCs are beginning 
to form a composite graft within the scaffold with polarity of the natural retina. For AMD 
and retinitis pigmentosa, degeneration begins in the outer retina, in the RPE and 
photoreceptor layers, respectively. As disease advances, the inner layers become affected 
as well, with remodeling and retraction of neuron processes and death of the inner retina 
[77, 85, 86]. To treat advanced retinal diseases, an ideal graft would have the ability to 
replace the different types of degenerating cells. Our results indicated an important step 
toward achieving this goal.  
In the mice transplantation experiments, the RPC scaffold graft demonstrated 
biodegradability and continued RPC survival in the host retina. Biodegradability is a useful 
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feature of scaffolds because it provides mechanical protection during the culture and 
transplantation process but can gradually degrade to allow RPCs to generate their own 
ECM and integrate with host cells. At 10 weeks post transplantation in RD10 mice, the 
scaffold had degraded and grafted RPC contributed to the native photoreceptor layer. 
Structurally, the transplantation was able to replenish the cells lost from degeneration. 
Additionally, some RPCs were observed to migrate deeper in the host retina. The migrating 
cells were not maturing photoreceptors because they did not express recoverin; therefore 
additional retinal markers need to be assayed to identify the migrating cells. It can be 
hypothesized that those cells were differentiating into neurons of the inner nuclear layer 
and were homing to the appropriate layers of the host retina. We also did not assay for 
functional integration of the transplanted RPCs. As a future experiment, tissue sections can 
be stained for synaptic proteins, such as α-transducin and PSD-95, to detect any synaptic 
integration between grafted and host cells [87, 88].  
It is known that photoreceptor loss increases significantly after 1 month of age in 
RD10 mice [77]. Therefore, we implanted the GCH-L521 RPC grafts when degeneration 
had begun in order to test for any functional recovery from our transplantation. On our 
functional testing in the transplanted RD10 mice, the mfERG did not show an effect from 
the implantation. Additional work, both in graft culture and functional testing, needs to be 
done to achieve the goal of demonstrating functional visual recovery. mfERG is a relatively 
new method for measuring retinal function in rodent studies. More commonly, a full-field 
ERG is used to assess visual function, which calculates a summary electrical signal from 
the entire stimulated area. mfERG divides the stimulated area into smaller segments and 
measure the retinal signal, so that signal waveforms can be correlated to specific stimulated 
 49 
areas (Figure 19). This feature is useful for evaluating the efficacy of transplantation 
because the implantation area is relatively small within the whole retina. Therefore, 
mfERG would be able to discern changes in retinal function specifically at the transplant 
site, which may not be discernable if full-field ERG were used. However, a trade-off to 
having geographic specificity is that the measured signals are weaker, which often requires 
recordings over several minutes. The parameters for applying mfERG to mice is still being 
optimized, such as stimulus frequency and intensity, and landmarks for visualization [89]. 
To improve on our RD10 mouse mfERG measurements, mfERG monitoring can start 
earlier and more frequently to detect any small effects of the procedure. One technical 
change that may improve mfERG measurements and reduce background noise is to record 
ERG signals for up to 10 minutes [89]. Additionally, new instrument hardware is available 
that can provide higher intensity of the stimulation light, which may improve the retinal 
response and the mfERG signals.  
 To move research toward human treatments, large animal studies can lead to further 
optimization of therapeutic methods because of increased anatomical and physiologic 
similarity to human tissues. Previous studies of retinal transplantation in pigs implanted 
RPE cells or RPCs that were in suspension, with good tolerability, graft survival and 
possible integration of transplanted cell within the host [56-58, 90]. Our pilot study tested 
the feasibility of transplanting a 3-D RPC scaffold graft and controlling the adverse effects 
of the procedure. The preliminary data indicated good tolerability of the graft with no 
significant difference in immune reaction between the transplanted and non-transplanted 
eye. Our immunosuppression protocol, one dose of prednisone a week before surgery and 
daily prednisone (2mg/kg) after surgery, was sufficient to control any inflammatory and 
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immune processes. Immunosuppression was needed in our study because we transplanted 
cells derived from human ESC. Our implanted cells did have limited migration into the 
host retina. However, this may be due to the short follow-up period for tissue analysis; our 
experiments did not go past four weeks post-transplantation. At that time, the scaffold had 
not degraded in the subretinal space, and may be limiting the interaction between grafted 
and host cells.    
 As discussed in the results section, the pig transplantation study encountered 
several technical challenges. The complications associated with surgery was expected as 
part of the learning curve of a large animal study, and were quickly minimized with 
increased experience. However, obtaining consistent and valid measurements on mfERG 
and OCT were larger challenges to overcome. Additional methods of reducing signal 
artifacts need to be tested to gain reliable mfERG readings. For example, more extensive 
electromagnetic shielding of the operating room may be required to reduce background 
noise [91]. Also obtaining mfERG immediately after anesthesia of the animal may also 
improve quality of measurements [91].   
 The long-term goal of this project is to develop a viable retinal graft capable of 
restoring visual function. An ideal graft would include all the cell types lost in the 
degenerative process. With our initial success in culturing RPC on a 3-D scaffold, our lab 
is exploring the effects of co-culturing the RPC scaffold culture with a RPE monolayer. 
Reciprocal interaction between RPE and developing RPCs may facilitate further 
maturation of retinal cells than monoculture alone. Bruch’s membrane, the basement 
membrane on the basal side of RPE cells, has also been shown to play a role in retinal 
development. In the developing chick retina, Bruch’s membrane promotes proper 
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polarization of membrane proteins in RPE cells [92]. Indeed, flat polymer scaffolds have 
been synthesized to mimic Bruch’s membrane to better culture RPE cells [93-95]. As a 
future direction, we can consider co-culturing our 3-D RPC scaffold graft with RPE 
monolayers cultured on synthetic Bruch’s membrane, to form a graft that mimics native 
retina even more closely. Additionally, the ability to generate tissue similar to native retina 
in culture offers the possibility for more effective pharmacologic testing ex vivo before 
moving to animal studies. 
 Overall, this project demonstrated that a novel laminin-521 coated porous scaffold 
can support growth and differentiation of ESC-derived RPCs. RPC GCH-L521 grafts were 
able to survive in the subretinal space of RD10 mice and exhibited some degree of 
migration within the host retina. These scaffold cultures can also be translated into studies 
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